FIELD: medicine, oncology.
SUBSTANCE: the present innovation deals with total hyperthermia along with chemotherapy. Moreover, as chemotherapeutic preparation one should apply an inhibitor of topoisomerase-1 injected 24-36 h after hyperthermia. The method enables to decrease medicinal loading during the period of hyperthermia, increase safety and controllability of procedure, improve anti-tumor efficiency due to optimal time for injecting the preparation mentioned.
EFFECT: higher efficiency of optimization.
1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THERMAL CHEMORADIATION OF ADVANCED NON-SMALL CELL LUNG CANCER | 2014 |
|
RU2548770C1 |
METHOD OF COMBINATION TREATMENT OF OPERABLE NON-SMALL CELL LUNG CANCER STAGE III | 2015 |
|
RU2590866C1 |
METHOD OF COMBINATION TREATMENT OF NON-SMALL CELL LUNG CANCER STAGE 1B-111 WITH CUSTOMIZATION OF ADJUVANT CHEMOTHERAPY | 2015 |
|
RU2593342C1 |
ONCOLYTIC TREATMENT METHOD FOR BREAST CANCER | 2018 |
|
RU2695136C1 |
METHOD FOR COMBINED TREATMENT OF STAGE III NON-SMALL CELL LUNG CANCER USING THERMOCHEMI-RADIOTHERAPY | 2017 |
|
RU2654612C1 |
METHOD FOR COMBINED TREATMENT OF STAGE II-III NON-SMALL-CELL LUNG CANCER | 2017 |
|
RU2636869C1 |
METHOD FOR PREDICTION OF RISK OF HEMATOGENOUS METASTASES IN NON-SMALL-CELL LUNG CANCER PATIENTS AFTER OPERATION | 2019 |
|
RU2733160C1 |
METHOD OF TREATING RECURRENT NON-SMALL CELL LUNG CANCER | 2014 |
|
RU2558473C1 |
METHOD FOR THE TREATMENT OF PERITONEAL CARCINOMATOSIS IN OVARIAN CANCER | 2021 |
|
RU2745478C1 |
METHOD FOR COMBINED TREATMENT OF NON-SMALL CELL LUNG CANCER IB-III STAGE USING PERSONALIZED PERIOPERATIVE CHEMOTHERAPY | 2019 |
|
RU2706718C1 |
Authors
Dates
2004-07-20—Published
2002-02-05—Filed